Our Members
As a member-focused Association, our members are at the heart of everything we do at the PRI.
In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.
Find out more about the different ways you and your organization can get involved with the PRI’s activities.
- Microbiome Regulatory Science Support Work
- Pre-competitive Task Groups
- Year-round networking and project-related communication support
Nearly 90 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.
Select Microbiome Activity Segment
- All segments
- Microbiome Product Developer
- Microbiome Analysis Expertise (service provider)
- Microbiome Pre-Clinical Research (CRO)
- Microbiome Clinical Research (CRO)
- Microbiome Contract Manufacturing Organization (CMO)
- Microbiome Contract Development & Manufacturing Organization (CDMO)
- Other Expertise | Quality, Legal, IP, Regulatory Affairs, Management
- Microbiome Research & Technology (public)
- Investment | Incubator | Accelerator | Tech Transfer
- Pharma (Human)
- Pharma (Veterinary)
- Diagnostics
- Consumer Goods
- News & Events
- PRI Publications
- PRI Member Job Openings
- Association Ambassadors
Select Country
Accelsiors AG
Hélène Cvejic
Director Translational Science and Clinical Research Hubs
Accelsiors is a leading international CRO. We support and accelerate each step of the clinical drug development, from the preclinical consultation stage throughout the whole clinical development.
ADM
As one of the world’s largest nutrition companies, ADM is a leader in both human and animal nutrition.
Aptar CSP Technologies
Francois Bidet
Vice-President of Business Development
Aptar CSP Technologies provides highly engineered packaging solutions to meet Probiotics stability needs. Through our Activ-Polymer, moisture and/or oxygen levels are reduced allowing a longer shelflife.
Astel Medica
Nail Nasir
Scientific Manager
Astel Medica is a fast growing belgian pharmaceutical company. Founded in 1988 with the collaboration of the University of Liège, Astel Medica is the Belgian leader in the conception and manufacturing of innovative evidence based symbiotics. Working in collaboration with 7 universities, Astel Medica invests in Research and Development as to provide the best Probiotics on the market.
Atlantia Clinical Trials
We are a world-class provider of human clinical studies. We perform acute, observational, PK/PD, pivotal, efficacy, and intervention studies to ICH-GCP standards for microbiome products.
University of Antwerp
Sarah Lebeer
Research Professor
Our 'Laboratory of Applied Microbiology and Biotechnology' is specialized in academic fundamental and applied research on the human microbiome (mainly vagina, upper respiratory tract & skin) and how microbiome-based therapeutics can be developed based on microbiome insights. We have a particular interest for lactobacilli in different parts of the human body and expertise in how to formulate these lactobacilli in suitable application forms for different bidy sites and how to run clinical trials to show clinical and microbiome efficacy.
Bacthera
Oliver Ravn
Marketing and Market Intelligence Associate
Leading CDMO in the LBP industry
BaseClear BV
Radhika Bongoni
Commercial Director
Founded in 1993, we are a pioneer on the market and have been on the forefront of the microbial genomics revolution. We are the preferred partner for many leading brands in various industries such as human health, personal care and animal nutrition in the Netherlands, in Europe and beyond. We support our clients in improving their processes and products, gaining approval and confirming claims.
Bio-Me AS
Warren Flood
CEO
Powering Microbiome Research and Diagnostics Development: qPCR-based platform is transforming microbiome analysis by enabling high-volume precision microbiome profiling.
BIOASTER
Established in 2012, BIOASTER is a private, non-profit Foundation that works to develop innovative technologies to support the latest challenges in microbiology research.
Biofortis
Françoise Le Vacon
CSO
Biofortis is a unique full services CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health.
Biomeostasis
Bruno Bariohay
CEO
BIOMEOSTASIS provides preclinical in vivo pharmacology services in the field of metabolic, GI and aged-related disorders.
Biomica
Elran Haber
CEO
Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI related disorders.
Boehringer Ingelheim
Anne Cadoux
Head of Regulatory Affairs Animal Health Care Products
Boehringer Ingelheim Animal Health France is born from Merial in 2018 further to the acquisition of Merial by Boehringer Ingelheim, a large pharmaceutical company with a small Animal Health department. Now 2nd biggest company in the world for Animal Health products. Innovation is one of its characteristics.
BoobyBiome
Lydia Mapstone
Co-Founder & CEO
BoobyBiome, a female-led UK-micro SME, is developing a rationally-designed live biotherapeutic product (LBP) tailored for babies with compromised microbiomes. Informed by rigorous scientific testing and precise characterisation of breast milk, the LBP will replenish the infant gut to a healthier state.
Caelus Health
Luc Sterkman
CEO
Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialization of microbiota-based products to prevent and treat cardiometabolic disorders, including Diabetes, and other unmet medical needs. The company has built a strong patented-protected proprietary position for the treatment of Diabetes Mellitus Type 1 and Type 2, cancer cachexia and auto-immune diseases.
Clinical Microbiomics
Anders Grøn
Chief Executive Officer
Clinical Microbiomics is the world's leading provider of metagenomics analyses advancing microbiome analyses across industry and academia.
CosmosID
Mo Langhi
Director, Business Development
CosmosID® is a global leader in supporting the pharmaceutical sector with CLIA-certified, ICH-GCP compliant microbiome and microbial isolate solutions for applications such as pre-clinical, clinical, CMC and regulatory support. In addition to Next Generation Sequencing workflows, CosmosID also offers validated, industry-leading bioinformatics, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision.
Cryptobiotix
Aurélien Baudot
CEO
Early & late preclinical research for a fast & informative gut microbiome product development.
Destiny Pharma
Debra Barker
CMO
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention.
Don Whitley Scientific Limited
Andrew Pridmore
Head of Science
GLP compliant contract microbiological laboratory services, specializing in antibiotic susceptibility testing and cultivation of highly fastidious bacterial strains.
DTU Biosustain
Jen Kindtler
VP Research and Development
ETH Zurich
Christophe Lacroix
Professor
Public university
everImmune
Karine Roget
CSO (interim)
everImmune leverages the potential of the gut microbiota for the development of therapeutic (Oncobax®) and diagnosis tools in cancer.
Ferring Pharmaceuticals
Michelle Carr
Senior Growth Project Manager
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives.
FNRS UCLouvain – Metabolism & Nutrition (MNUT)
Amandine Everard
Professor
Academic research in microbiome at University (Univeristé Catholique de Louvain - UCL)
Freya Biosciences
Johan E.T. van Hylckama Vlieg
CSO & Co-founder
Freya™ is a clinical-stage company taking an innovative approach to women’s health, with microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of reproductive system diseases uniquely afflicting women.
GenoScreen
Pierre Burguière
Deputy CEO
GenoScren is a French biotech with 20+ years of expertise – we develop cutting-edge end-to-end analytical solutions to decipher microbiome (gut, skin, soil) compositions and functions.
GMT Science
Etienne Formstecher
CEO
GMT Science develops routine, CE-marked microbiome analysis to improve the clinical management of chronic diseases.
Hallym University
Suenie Park
Professor
Hallym University is a four-year private university set at the foot of Bong Ui Mountain in central Chuncheon. Since its foundation in 1982, the university has strived to nurture its students into leaders of tomorrow. Located one-hour east of Seoul and served by world class transportation links, Chuncheon serves as the gateway as well as the capital of the province of Gangwon-do.
Hospital-ASST Bergamo Est
Fabio Pace (MD)
GI Unit Director
ASST Bergamo Est Hospital
Lombardy region, Italy
ICO
Sidonie LAVERGNE
Scientific Director & Director of Translational Research
Integrated Cancer Center
ICOSA
Caroline de Mareuil-Villette
European Patent Attorney
ICOSA is a Patent Law Firm specialized in Healthcare, and deeply involved in protecting microbiome-related inventions.
IFF
Charlotte Storni
Global Regulatory Strategy Lead Biopharma
Inspired by nature and distinguished by our world-class bioscience and microbiome capabilities, IFF’s Health & Biosciences (H&B) division is a leading innovation partner for customers across a broad range of markets and industries.
INRAE
Patrick Veiga
Gut Microbiome & Nutrition Research Research Director
INRAE is committed to exploring the frontiers of science and performing high-calibre research that is globally relevant. The institute makes major contributions to European research and participates in European research programmes (e.g., via research networks, H2020 research projects, Marie Skłodowska-Curie Actions) and, as a result, is currently developing bilateral and trilateral partnerships. Our international collaborations focus on sharing laboratories or infrastructure, becoming integrated into research networks, and playing a role within international organisations.
INRAE Transfert Genome and Transcriptome
Marina Moletta-Denat
Business development
GeT-IT offers a range of services based on innovations from INRAE that meet the expectations and needs of companies in genomic and transcriptomic applications or R and D projects.
Institut Pasteur Lille France
Catherine DANIEL
Principal Investigator, Senior Researcher
Cancers, infectious diseases (COVID-19, tuberculosis, whooping cough, etc.), cardiovascular diseases, Alzheimer's disease, inflammatory diseases, diabetes, ...34 research teams are working every day to understand and fight against these diseases, to slow their development, to imagine tomorrow's treatments and to change behavior.
Lactosan GmbH
Peter Ladinig
Head of production
Lactosan Pharma offers contract manufacturing for APIs basing on microorganisms according to GMP/cGMP standards. The production plant features a 1,000 l fermentation tank and a freeze-drying unit.
Lallemand Health Solutions
Sylvie Binda
Vice President Research & Development
Pioneer in the probiotic industry since 1934, LHS provides probiotic products with solid scientific research, custom formulations and unique customer service to its partners in more than 60 countries.
Mbiomics Gmbh
Markus Rinecker
Managing Director and Co-Founder
mbiomics offers a unique combination of fast, quantitave and accurate analysis of the microbiome.
Metabolon
Raffy Demirdjian
Sales and Business Development Director, France & Belgium
Metabolon, Inc. is the global leader in metabolomics, with a mission to deliver biochemical data and insights that expand and accelerate the impact of life sciences research.
Microbiotica
Adam Wilkinson
VP Pre-Clinical Development
Microbiome biomarker and drug development company with a world-leading microbiome analysis platform.
MRM Health NV
Selin Bolca
Director Pharmaceutical Development and Manufacturing
Unlocking the full potential of the gut microbiome for development of effective therapeutics through our proprietary CORAL™ consortia optimization and single-process manufacturing technology.
NBX Biosciences
Damien Rei
CEO
Startup developing gut microbiota derived treatment against neurodegenerative diseases
Neobe Therapeutics
Pedro Correa de Sampaio
CEO
Neobe is building a platform for the engineering of live biotherapeutics aimed at removing stromal barriers to immune infiltration in solid tumours, in order to enable existing immunotherapies in current non responding cancer patients.
Nestlé Health Science
Laurent Ameye
Global Regulatory Compliance Manager
Our expertise areas includes food supplements, medical nutrition, and pharmaceutical solutions on areas including food allergies, metabolic/gastrointestinal health, healthy aging and adult acute care.
Nexbiome Therapeutics
Stanislas Desjonquères
CEO
We transform academic therapeutic and microbiome-based projects into products for Humans. Our value is to source, fund and operate these projects.
Orion Corporation Orion Pharma R&D
Mirja Huhtinen
Director, Animal Health R&D
Orion Pharma Animal Health R&D develops innovative medicinal, ProHealth and microbiome products to global markets. Our flagship microbiome product is Broilact.
PharmaBiome AG
Tomas de Wouters
Co-Founder & CEO
Pioneering the development of microbiome-based therapies using proprietary tools for their design and production.
Phycell (INSERM U1003) – University of Lille
Mathias Chamalliard
Research Director at INSERM - Deputy Director of the Laboratory of Cell Physiology
The Chamaillard laboratory is interested in defining how mucosal immune response to the microbiota contribute to microbial tolerance, host defense and antitumoral immunity, and how deregulation of these processes break down in Crohn's disease and colitis-associated colorectal cancer. Crohn's disease affects millions of individuals worldwide through the influence of several genetic and environmental factors.
PiLeje
Pascaline Gervoson
CEO
PiLeJe’s purpose is to promote the health of each individual and maintain it for as long as possible. This is achieved by applying what Dr Christian Leclerc, the Group’s founder, calls “health-based medicine”.
POSTECH
Sin-hyeog Im
Professor
Pohang University of Science and Technology is devoted to nurturing the leaders who make a difference globally, conducting cutting-edge research with outcomes that transform our daily lives, and directly contributing to the betterment of society through science and technology.
Probiotical Research
Marco Pane
CSO
Probiotical is an Italian family-owned company specialized since 1985 in probiotics manufacture, from the raw material to the finished products, with very high quality, guaranteed stability and scientifically backed strains. We are driving innovation in a variety of functionalities and technologies.
ProDigest BV
Massimo Marzorati
CEO
The most complete in vitro technology platform (from high-throughput to detailed MoA) to assess the fate of Microbiome-based medicinal products along the GI tract.
PROGE FARM S.r.l.
Antonella Bonetti
Regulatory Affairs Manager
PROGE FARM develops, produces, registers (even as medicine) and put on the markets, directly or through licensees, its products based on selected patented probiotic strains.
Quadram Institute
Graeme Brown
CBO
At the forefront of research into food, the gut microbiome, and human health, the Quadram is a unique partnership between Quadram Institute Bioscience, the Norfolk and Norwich University Hospitals NHS Foundation Trust and the University of East Anglia (UEA).
Recolony
Ana Montalban-Arques
CEO Recolony
Recolony focuses on the development of a live biotherapeutic product for the treatment or prevention of colorectal cancer.
Sanofi Consumer Healthcare
Seventure Partners
Isabelle de Cremoux
CEO & Managing Partner
Seventure Partners finances the development of innovative companies within Life sciences and Digital technologies. We have 20 years of experience which has enabled Seventure to acquire expertise and networks in these two fields which services the needs of entrepreneurs.
Siolta Therapeutics
Nikole Kimes
CEO & Founder
Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based medicines.
Spanish National Research Council (IATA-CSIC)
Yolanda Sanz
Full Professor
Microbiome, Intestinal Human Bacteria, Immunity, Body-Brain Interactions, Diet, Obesity, Diabetes, Cardiovascular Disease, Mood, Comorbidities, Microbiome-Based Diagnosis, Prevention and Therapy, Microbiome-Directed Nutrition.
Starfish Bioscience
Sandrine Claus
Founder & CEO
Regenerating soil microbiomes
Taiwan Microbiota Consortium
Chun-Ying Wu
Chair
Univ Beira Intérior
Ana Palmeira-de-Oliveira
Invited Professor
The University of Beira Interior (UBI), is a Portuguese institution of higher education in expansion, reaching the status of academy, which welcomes students from all regions of the country and international students from dozens of nationalities, namely from Portuguese-speaking countries and Latin America.
UMRF 0545 / Université Clermont Auvergne
Stéphanie Bornes
Professor
Université Grenoble alpes
Audrey Le Goellec
MCU-PH
A multidisciplinary institution located in the heart of the French Alps, Université Grenoble Alpes (UGA) is renowned for its scientific and technological research activities, aimed at providing essential training to students and faculty and at addressing societal issues.
University College Cork
Siobhain O'Mahony
Lecturer and Principal Investigator
World-class Undergraduate and Postgraduate Education in Ireland
University of Ghent
Tom Van de Wiele
Full Professor
Ghent University is a top 100 university and one of the major universities in Belgium. Our 11 faculties offer more than 200 courses and conduct in-depth research within a wide range of scientific domains. Ghent University Global Campus is also the first European university in Songdo, South Korea.
University of Queensland Australia
Anders Cervin
Professor
The University of Queensland (UQ) is one of Australia’s leading research and teaching institutions. We strive for excellence through the creation, preservation, transfer and application of knowledge. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world.
VetAgro Sup
Laurent Rios
Professor
VetAgro Sup is an institution of higher education and research (ESR) under the aegis of the French Ministry of Agriculture and Food. It is the only establishment in France that trains veterinarians, agricultural engineers, and veterinary public health inspectors.
Voisin Consulting Life Sciences (VCLS)
Clara Desvignes
Director, Drugs, Medical Devices & Microbiome-based products
VCLS collaborates with developers to strategically position their microbiome-based products, creating a roadmap to hit product development milestone, and achieve the commercial success.
Yakult Europe BV
Bruno Pot
Science Director Europe
Global probiotic product producer.
Zymo Research Europe GmbH
Dr. Thomas Kuri
Managing Director
Zymo Research is a globally established biotechnology company and industry leader in the fields of epigenetics, microbiomics and the emerging Next-Gen Sequencing space.
